Steve Weinstein
Venture Investor, CEO and Life Science Executive
Greater Boston
Invests in
Locations:
Min Investment:
$5,000.00Max Investment:
$50,000.00Target Investment:
$25,000.00
Skills
Education
Lists including Steve
Investments
Work Experience
2024
Senior Advisor
2024
UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC.
Innovation Consultant
2024
2025
Expert-in-Residence (XIR)
2025
Advise ARPA-H on how to translate their programs from bench to bedside. Advise innovators working on early-stage healthcare technologies.
Strategic Advisor
2019
Clinical research and commercial translation strategy related to mental health, neuomodulation, addiction, and digital tools in clinical practice.
2018
Managing Member
2018
Consultant and Advisor to Venture Funds, Venture Funded Start-ups & Academic Medical Centers
Product Development Review Council Member
2018
Council reviews oncology-focused grants of up to $20M/company.
2021
Board Member
2021
CEO
2021 - 2023
• Joined as Independent Director. Became Interim CEO to build senior leadership team including CSO, CMO, and Data Science. Developed new R&D and clinical strategy. • Development stage prostate cancer prognostic for monitoring patients with low risk tumors.
2021
Board Member
2021
Developing an ingestible drug/device which detects and reverses opioid overdose.
2021 - 2024
Consultant, Neuroscience Innovation
2021 - 2024
• Evaluate technologies and manage projects that transform the treatment of neurological diseases including neuromuscular, precision psychiatry, and drug delivery. • Developed best practices recommendations for corporate innovation.
2019 - 2024
Chairman
2019 - 2024
• Next generation intravascular cardiology imaging combining DeepOCT™ imaging, near infrared spectroscopy (NIRS), and AI-powered insights to optimize coronary stenting and better inform care.